173 related articles for article (PubMed ID: 25851301)
1. Diagnosis of invasive aspergillosis: recent developments and ongoing challenges.
Arvanitis M; Mylonakis E
Eur J Clin Invest; 2015 Jun; 45(6):646-52. PubMed ID: 25851301
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
3. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
[TBL] [Abstract][Full Text] [Related]
4. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Danylo A; Courtemanche C; Pelletier R; Boudreault AA
Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
[TBL] [Abstract][Full Text] [Related]
6. The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.
Ambasta A; Carson J; Church DL
Med Mycol; 2015 Aug; 53(6):531-57. PubMed ID: 26026174
[TBL] [Abstract][Full Text] [Related]
7. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
[TBL] [Abstract][Full Text] [Related]
9. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal infections: biomarkers and molecular approaches to diagnosis.
Schuetz AN
Clin Lab Med; 2013 Sep; 33(3):505-25. PubMed ID: 23931836
[TBL] [Abstract][Full Text] [Related]
11. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
[TBL] [Abstract][Full Text] [Related]
12. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
Einsele H; Loeffler J
Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
[TBL] [Abstract][Full Text] [Related]
13. Detection of invasive aspergillosis.
Thornton CR
Adv Appl Microbiol; 2010; 70():187-216. PubMed ID: 20359458
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.
Oz Y; Kiraz N
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):289-98. PubMed ID: 21417868
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of galactomannan antigen detection to early diagnosis of invasive aspergillosis].
Rácil Z; Kocmanová I; Wagnerová B; Winterová J; Mayer J
Klin Mikrobiol Infekc Lek; 2007 Oct; 13(5):176-83. PubMed ID: 17987566
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for invasive aspergillosis: the challenges continue.
Johnson G; Ferrini A; Dolan SK; Nolan T; Agrawal S; Doyle S; Bustin SA
Biomark Med; 2014; 8(3):429-51. PubMed ID: 24712434
[TBL] [Abstract][Full Text] [Related]
17. Application of diagnostic markers to invasive aspergillosis in children.
Roilides E; Pana ZD
Ann N Y Acad Sci; 2012 Dec; 1272():1-8. PubMed ID: 23231708
[TBL] [Abstract][Full Text] [Related]
18. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
Shahid M; Malik A; Bhargava R
Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
[TBL] [Abstract][Full Text] [Related]
19. Laboratory diagnosis of invasive aspergillosis.
Hope WW; Walsh TJ; Denning DW
Lancet Infect Dis; 2005 Oct; 5(10):609-22. PubMed ID: 16183515
[TBL] [Abstract][Full Text] [Related]
20. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
Xie LP; Liu T; Meng WT; Zhou J
Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
